Your browser is no longer supported. Please, upgrade your browser.
Settings
XXII 22nd Century Group, Inc. daily Stock Chart
XXII [NYSE]
22nd Century Group, Inc.
Index- P/E- EPS (ttm)-0.13 Insider Own4.50% Shs Outstand92.63M Perf Week-2.44%
Market Cap148.21M Forward P/E- EPS next Y-0.09 Insider Trans- Shs Float73.00M Perf Month-11.60%
Income-11.00M PEG- EPS next Q-0.03 Inst Own7.90% Short Float6.44% Perf Quarter15.11%
Sales11.50M P/S12.89 EPS this Y10.40% Inst Trans0.52% Short Ratio4.69 Perf Half Y70.21%
Book/sh0.24 P/B6.67 EPS next Y0.00% ROA-48.50% Target Price3.50 Perf Year98.54%
Cash/sh0.12 P/C13.85 EPS next 5Y- ROE-57.40% 52W Range0.79 - 2.00 Perf YTD46.79%
Dividend- P/FCF- EPS past 5Y-23.10% ROI-46.30% 52W High-25.75% Beta2.83
Dividend %- Quick Ratio3.30 Sales past 5Y64.70% Gross Margin-7.20% 52W Low87.97% ATR0.09
Employees46 Current Ratio4.20 Sales Q/Q-26.70% Oper. Margin-97.60% RSI (14)36.08 Volatility3.53% 5.09%
OptionableYes Debt/Eq0.01 EPS Q/Q34.20% Profit Margin-95.30% Rel Volume1.64 Prev Close1.60
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume1.00M Price1.49
Recom2.00 SMA20-11.84% SMA50-7.98% SMA20020.24% Volume781,158 Change-7.19%
Aug-11-16Reiterated Chardan Capital Markets Buy $4.50 → $3.50
Jul-03-17 11:30AM  Top Ranked Momentum Stocks to Buy for July 3rd Zacks
Jun-30-17 04:09PM  Penny Stocks to Watch for July 2017 Investopedia
Jun-26-17 09:30AM  22nd Century Joins Russell Microcap® Index Business Wire
Jun-22-17 09:55AM  22nd Century Receives Guidance from FDA on Phase III Clinical Trials Business Wire
Jun-20-17 09:55AM  22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands Business Wire
Jun-16-17 09:25AM  22nd Century Meets with FDA on Modified Risk Tobacco Product Application for Worlds Lowest Nicotine Tobacco Cigarettes Business Wire
Jun-15-17 09:28AM  New International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes Business Wire +5.85%
Jun-13-17 07:09AM  New Frontier Data CEO On Collective Effort Behind Marijuana Legalization: Coming Together Helps The Whole Cannabis Industry Benzinga
Jun-09-17 04:23PM  Pot Stock Winners of the Week Investopedia
Jun-08-17 09:20AM  22nd Century and Dent Neurosciences Research Center to Partner on Brain Imaging Clinical Trial Business Wire
08:15AM  22nd Century Group (XXII) Jumps: Stock Adds 12.2% in Session Zacks
Jun-07-17 08:00AM  Today's Research Reports on Stocks to Watch: Egalet Corporation and 22nd Century Group Accesswire +12.20%
Jun-06-17 01:30PM  22nd Century Produces Non-GMO Very Low Nicotine Tobacco Business Wire +12.33%
Jun-01-17 09:45AM  22nd Century Group Receives Order for 2.4 Million SPECTRUM® U.S. Government Research Cigarettes Business Wire
May-31-17 07:15AM  Dramatic Surge in Very Low Nicotine Tobacco Clinical Trials and Science Business Wire
May-09-17 07:51AM  22nd Century Raises 2017 Revenue Projection to $16Million Another Record Year Business Wire +6.87%
05:32AM  22nd Century reports 1Q loss Associated Press
May-08-17 04:15PM  22nd Century Group Files 2017 First Quarter Report and Announces Conference Call to Provide Business Update Business Wire
May-01-17 06:55AM  FDA Authorizes Clinical Trial for 22nd Centurys BRAND B Low Tar-to-Nicotine Ratio Cigarettes Business Wire
Apr-25-17 09:45AM  22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China Business Wire
08:15AM  22nd Century Group (XXII) Jumps: Stock Adds 6.5% in Session Zacks
Apr-20-17 09:45AM  22nd Century Will Play Leading Role in Industrial Hemp Industry Business Wire
Apr-18-17 09:06AM  World-Renowned Smoking Cessation Scientist, Dr. Michael Cummings, to Present Keynote Address at 22nd Century Annual Shareholder Meeting Business Wire
Apr-06-17 09:44AM  Can The Uptrend Continue for 22nd Century Group (XXII)? Zacks
Apr-04-17 09:45AM  New Zealand Study Recommends 22nd Centurys VLN Cigarettes as an Effective Tobacco Control Strategy Business Wire
Mar-30-17 04:13PM  Collect Smokin' Hot Profits From This Marijuana Biotech TheStreet.com
09:50AM  22nd Centurys Non- or Minimally-Addictive Cigarettes Gaining Support of Leading Tobacco Scientists around the World Business Wire
Mar-29-17 09:45AM  22nd Century Invited to Speak at the Colorado Hemp Expo about the Companys Medical Marijuana Initiatives and Zero-THC Hemp Plants Business Wire +12.15%
Mar-23-17 09:45AM  22nd Century Produces Zero THC Industrial Hemp at Anandia Labs Business Wire +8.33%
Mar-21-17 09:50AM  22nd Century Group Issues Annual Letter to Shareholders Business Wire
Mar-14-17 01:04PM  22ND CENTURY GROUP, INC. Financials
Mar-08-17 06:54PM  22nd Century reports 4Q loss Associated Press
04:29PM  22nd Century Group Files 2016 Annual Report and Announces Conference Call to Provide Business Update Business Wire
04:14PM  22ND CENTURY GROUP, INC. Files SEC form 10-K, Annual Report
Mar-02-17 06:59AM  22nd Century Granted FDA Guidance Meeting for X-22 Smoking Cessation Aid Business Wire
Feb-28-17 06:59AM  22nd Century Provided with Written Feedback from FDA on the Companys Modified Risk Tobacco Product Application Business Wire
Feb-22-17 09:46AM  Crede Dismisses Claims in Lawsuit Against 22nd Century Business Wire +5.88%
Feb-03-17 09:45AM  22nd Century Prevails Again in Frivolous Crede Lawsuit Business Wire
Feb-01-17 09:45AM  LD Micro Index Reconstitution as of February 1, 2017 Accesswire
Jan-20-17 02:28PM  ETFs with exposure to 22nd Century Group, Inc. : January 20, 2017
Jan-09-17 02:26PM  ETFs with exposure to 22nd Century Group, Inc. : January 9, 2017
Jan-05-17 09:15AM  FDA Provides Positive and Encouraging Feedback for 22nd Centurys Very Low Nicotine MRTPA Filings Business Wire -14.15%
Dec-23-16 01:21PM  ETFs with exposure to 22nd Century Group, Inc. : December 23, 2016
Dec-20-16 11:03AM  22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure
09:50AM  22nd Century Group Announces Major Scientific Collaboration with University of Virginia Business Wire
Dec-12-16 03:04PM  ETFs with exposure to 22nd Century Group, Inc. : December 12, 2016
Dec-05-16 10:00AM  22nd Century to Present Overview of Companys Medical Marijuana and Industrial Hemp Initiatives at LD Micro Investor Conference Business Wire +18.89%
Nov-30-16 01:29PM  ETFs with exposure to 22nd Century Group, Inc. : November 30, 2016
Nov-14-16 02:47PM  ETFs with exposure to 22nd Century Group, Inc. : November 14, 2016
Nov-11-16 11:12AM  22nd Century Group, Inc. :XXII-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Nov-08-16 04:15PM  22ND CENTURY GROUP, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  22nd Century Group Files 2016 Third Quarter Report and Announces Conference Call to Provide Business Update Business Wire
Nov-02-16 09:45AM  Mandating a Reduction in the Nicotine Content of Cigarettes Would Likely Decrease Both the Rate and Prevalence of Smoking Business Wire
Oct-26-16 09:50AM  Former Santa Fe Natural Tobacco Company Executive Joins 22nd Century Business Wire
Oct-20-16 09:45AM  22nd Centurys Very Low Nicotine Cigarettes Significantly Reduce Withdrawal and Craving Symptoms in Vulnerable Population Groups Business Wire +6.03%
08:10AM  Reynolds American (RAI) Sinks to 52-Week Low: Here's Why
Oct-19-16 11:50AM  22nd Century Group Announces Closing of $11.4 Million Above-Market Registered Direct Offering Business Wire
Oct-18-16 11:23AM  ETFs with exposure to 22nd Century Group, Inc. : October 18, 2016
Oct-17-16 08:55AM  22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fi
Oct-14-16 08:45AM  22nd Century Group Announces Above-Market Offering for $11.4 Million Business Wire
Oct-13-16 09:45AM  22nd Century Very Low Nicotine Cigarettes Could Reduce U.S. Smoking Rates by More than 75% Business Wire
Oct-06-16 12:12PM  Phase III Clinical Trial with 22nd Centurys Very Low Nicotine Cigarettes Names Ten Major Research Institutions as Study Locations Business Wire
Oct-04-16 09:55AM  22nd Century Announces Expiration of 2,250,000 Crede Warrants Business Wire
Sep-29-16 09:52AM  ETFs with exposure to 22nd Century Group, Inc. : September 29, 2016 +7.46%
Sep-27-16 09:55AM  Overwhelming Physician and Consumer Support Cited for 22nd Centurys X-22 Very Low Nicotine Smoking Cessation Product Business Wire +7.76%
Sep-21-16 03:55PM  22nd Century Group to Present at The MicroCap Conference on October 24-25 in Philadelphia Accesswire
Sep-16-16 11:44AM  ETFs with exposure to 22nd Century Group, Inc. : September 16, 2016
Sep-06-16 11:28AM  ETFs with exposure to 22nd Century Group, Inc. : September 6, 2016
10:00AM  22nd Century Announces Expansion of Cannabis Research Program Business Wire
Aug-24-16 12:17PM  ETFs with exposure to 22nd Century Group, Inc. : August 24, 2016
Aug-12-16 02:51PM  ETFs with exposure to 22nd Century Group, Inc. : August 12, 2016
Aug-11-16 11:10AM  22nd Century Group, Inc. :XXII-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-09-16 04:15PM  22nd Century Group Files 2016 Second Quarter Report Announces Conference Call to Provide Business Update Business Wire
04:11PM  22ND CENTURY GROUP, INC. Files SEC form 10-Q, Quarterly Report
Aug-02-16 08:31AM  22nd Century Group (XXII) Catches Eye: Stock Rises 7.8% +8.87%
Jul-26-16 05:14PM  22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh
Jul-25-16 09:01AM  22ND CENTURY GROUP, INC. Files SEC form 8-K, Regulation FD Disclosure
09:00AM  22nd Century Group Announces $5.0 Million Registered Direct Offering at Market Business Wire
Jul-20-16 12:58PM  ETFs with exposure to 22nd Century Group, Inc. : July 20, 2016
Jul-14-16 08:45AM  Nicotine Reduction Strategy is Championed by Growing Number of Scientists and Public Health Experts Business Wire
Jul-11-16 01:15PM  World Health Organization Recommends Mandated Reductions in Nicotine to Minimally Addictive Levels Business Wire
Jun-28-16 09:45AM  22nd Centurys Very Low Nicotine Cigarettes Reduce Smoking and Are Now Associated with Reduced Alcohol Use Business Wire
09:31AM  These Biotech Companies Are Prime For a Breakout as the Market for Smoking Cessation Products Heats Up
Jun-22-16 09:55AM  New Study Shows Cigarettes Containing 22nd Centurys Proprietary Tobacco Reduce Smoking and Toxicant Exposure Business Wire
08:07AM  Will Medical Marijuana Take Biotech Stocks To A New High
Jun-20-16 05:22PM  Which Stocks To Watch Ahead Of The Potential Us-Wide Federal Legalization Of Medical Cannabis
Jun-16-16 09:44AM  22nd Centurys Proprietary SPECTRUM® Cigarettes Identified as Crucial Tool in Human Addiction Studies Business Wire +6.93%
Jun-15-16 10:47AM  Federal Government Potential Green Signal to Cannabis Could Propel Cannabis Stocks
Jun-07-16 12:26PM  Demand Continues to Surge for Cannabis & Industrial Hemp Products While Becoming a Cornerstone for Financial Stability for Growers & Processing Facilities CNW Group
Jun-06-16 07:02AM  Antidote Company's Valuation Misaligned With Growing Crisis
May-28-16 03:11PM  How Hedge Funds Traded Marijuana Stocks in Q1 at Insider Monkey
May-27-16 09:22AM  22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals Business Wire
May-25-16 08:30AM  22nd Century Launches MAGIC 0 Very Low Nicotine Cigarettes in France Business Wire
May-24-16 10:23AM  Independent Phase II and III Clinical Studies on 22nd Century's Smoking Cessation Technology Highlighted on New Heracles Website Business Wire +6.01%
May-19-16 10:29AM  22nd Century to Make Proprietary Research Cigarettes Available Worldwide to Scientists, Researchers, and Governments Business Wire
May-17-16 04:36PM  22nd Century Group, Inc. :XXII-US: Earnings Analysis: Q1, 2016 By the Numbers +8.61%
May-12-16 08:49AM  22nd Century Launches Major New Initiative to Produce Medically-Important Marijuana Cannabinoids Business Wire
May-10-16 04:24PM  22ND CENTURY GROUP, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  22nd Century Group Files 2016 First Quarter Report and Announces Conference Call to Provide Business Update Business Wire
May-06-16 12:30PM  CEOLIVE.TV Announces New Interview With Gregg Gellman, Director of Business Development for 22nd Century Group, Inc. Marketwired
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The company's products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than conventional tobacco cigarettes, as well as BRAND B cigarettes that contain low amount of tar per milligram of nicotine. 22nd Century Group, Inc. has a scientific collaboration with the University of Virginia; and a strategic partnership with Anandia Laboratories, Inc. The company was founded in 1998 and is headquartered in Clarence, New York.